Plain-English translation of NCT07359105 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a personalized cholesterol-lowering approach works as well as standard statin therapy for preventing heart disease in older adults with type 2 diabetes. Statins are the most common cholesterol medications, and doctors have been recommending a moderate dose for people your age. However, researchers want to know if tailoring the treatment to each person's individual needs—by setting a specific cholesterol target based on their health history and preferences—might work just as well or better.
Most studies on cholesterol-lowering medications have focused on younger people or those who have already had a heart attack or stroke. There is a real gap in knowledge about what works best for older adults who have diabetes but have never had heart disease. This trial aims to fill that gap and help doctors make better, more personalized treatment decisions for this group.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: one receiving standard moderate-intensity statin medication, or another receiving an individualized cholesterol-lowering plan tailored to your specific health situation, risk factors, and preferences. Your doctor will work with you to decide on a cholesterol target that makes sense for you. The study will track whether you experience a first-time cardiovascular event and how well each approach works over time.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea